Watchlist Price Alert

Protagenic Therapeutics I... (PTIX)

NASDAQ: PTIX · Real-Time Price · USD

3.52

0.13 (3.83%)

At close: Jun 17, 2025, 3:59 PM

3.64

3.41%

After-hours: Jun 17, 2025, 07:58 PM EDT

3.83% (1D)

Bid	3.33
Market Cap	3.06M
Revenue (ttm)	n/a
Net Income (ttm)	-5.24M
EPS (ttm)	-13.13
PE Ratio (ttm)	-0.27
Forward PE	n/a
Analyst	n/a

Ask	3.71
Volume	301,723
Avg. Volume (20D)	2,043,747
Open	3.45
Previous Close	3.39
Day's Range	3.37 - 3.74
52-Week Range	2.35 - 15.82
Beta	0.38

About PTIX

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol PTIX

Website n/a

Full Company Profile

Why Price Moved

1 month ago

Protagenic Therapeutics shares are trading higher ... Unlock content with Pro Subscription

1 month ago

Protagenic Therapeutics shares are trading lower. The company reported Q1 financial results.

News

3 weeks ago · accessnewswire.com

Protagenic Therapeutics Receives $3.1 Million from Recent Warrant Activity

NEW YORK, NY / ACCESS Newswire / May 21, 2025 / Protagenic Therapeutics, Inc. (Nasdaq:PTIX) (the "Company") announced today that warrant exchanges and exercises over the last four trading days have ge...

1 month ago · benzinga.com

Gold Gains Over 1%; Protagenic Therapeutics Shares Spike Higher

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 150 points on Monday.

4 weeks ago · businesswire.com

PTIX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Protagenic Therapeutics, Inc. Is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Protagenic Therapeutics, Inc. (NASDAQ: PTIX) and Phytanix Bio Inc. is fair to Protageni...

4 weeks ago · accessnewswire.com

Protagenic Therapeutics and Phytanix Announce Business Combination to form Neuroactive Biopharmaceutical Company with Six Drug Candidates in Development including Treatments for Obesity and Metabolic Disorders

NEW YORK, NY AND SANTA BARBARA, CA / ACCESS Newswire / May 19, 2025 / Protagenic Therapeutics, Inc. (Nasdaq:PTIX) (the "Company") and Phytanix Bio Inc. have entered into a definitive share exchange ag...

1 month ago · accessnewswire.com

Protagenic Therapeutics to Effect 1-for-14 Reverse Stock Split

Measure taken to Comply with Nasdaq Rule 5550(a)(2) Regarding Minimum Bid Price NEW YORK, NY / ACCESS Newswire / April 29, 2025 / Protagenic Therapeutics, Inc. (Nasdaq:PTIX) ("Protagenic Therapeutics"...